anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

List

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,471
Current window 78,241-78,270
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all
18 30 60

Component

78,241-78,270 of 110,471

filter-aware
10
Data as of March 19, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
12
The chart is a swimmer plot, a common clinical trial visualization for patient-level response over time.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
14
The chart is a swimmer plot, a common visualization in oncology clinical trials to show patient-level treatment duration and response.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
16
The slide details specific patient cohorts categorized by dosage and tumor type/treatment history.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
17
Data cut off May 3, 2021. Includes patient-level data for 7 patients.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
19
Data cut off May 3, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
26
Includes both longitudinal line charts and bar charts for maximum fold change.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
27
Includes patient timeline, biomarker (CA-125) trend, target lesion size comparison, and CT scan imagery.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
03
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
04
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
08
Includes data on wholesale units by model, geographic wholesale change, wholesale ASP, and total retail units.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Bridge1 hit
09
The chart illustrates the decline in revenue across four key segments: Sale of vehicles, Sale of parts, Servicing of vehicles, and Brand and motorsport.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Bridge1 hit
10
The slide uses a waterfall chart to bridge financial performance between two years, highlighting specific operational and market impacts.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The BridgeLoop · Before After1 hit
11
The chart uses a standard waterfall bridge format to reconcile PBT to Free Cash Flow.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Before After1 hit
15
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Quick Win Big Bet1 hit
17
The slide outlines a transition from current models to future electrified/BEV models using Mercedes-Benz technology.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
18
The slide uses a dark, high-contrast aesthetic typical of luxury automotive branding.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
21
Includes footnotes regarding model definitions and data restatements.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
26
This is a standard financial disclosure slide defining non-GAAP metrics.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
02
The slide uses a numbered list format to present progress on 'Project Horizon'.Aston Martin | Results Presentation Deck | 12 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Attention1 hit
05
The slide uses a waterfall bridge to explain the variance in Adjusted EBITDA between two periods.Aston Martin | Results Presentation Deck | 12 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses two separate waterfall charts to bridge cash and net debt positions.Aston Martin | Results Presentation Deck | 12 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
This slide provides the methodology/definitions for non-GAAP financial metrics used in the presentation.Aston Martin | Results Presentation Deck | 12 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit
04
The slide uses a column-based layout to segment the portfolio by therapeutic area.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
07
AstraZeneca | Investor Day Presentation Deck | 40 slidesAstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
10
Includes a Kaplan-Meier survival curve and a bar chart showing patient reach growth.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The slide uses a color-coded legend to distinguish between approved indications and ongoing trials across the disease continuum.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
21
The slide uses a three-column layout to compare different drug assets in the pipeline.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
33
The slide uses a cell cycle diagram for DDR, a triangular framework for IO, and a list of modalities.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
35
Slide 35 of a presentation, likely from AstraZeneca.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit